Results at a glance - Evaluation of the Coordination of Antimicrobial Resistance (AMR) Activities at the Public Health Agency of Canada (PHAC)   



What the evaluation found

Recommendations and responses

  1. PHAC should clearly articulate its roles, responsibilities and priorities to address AMR within the federal and pan-Canadian landscape.
    Response: PHAC will develop and share statement on PHAC roles and long-term objectives on AMR.
  2. PHAC should have open and regular communications with its federal and pan-Canadian partners on its role, responsibilities and priorities in addressing AMR, and on current work and next steps to meet federal and pan-Canadian commitments.
    Response: PHAC will develop and share a stakeholder engagement plan.
  3. PHAC should establish the necessary structures to ensure all of its AMR activities, including policy and surveillance, are coordinated efficiently or integrated, where relevant. It should also continue work to establish an AMR program with clear accountability to accomplish its role in addressing AMR.
    Response: PHAC will examine existing activities and desired results vis-à-vis PHAC roles and responsibilities.
  4. PHAC should make every effort it can to ensure the timely release of the pan-Canadian Action Plan by summer or early fall of 2019.
    Response: PHAC will review and revise the critical path for the pan-Canadian Action Plan.

About this evaluation

This evaluation examined the design, delivery and coordination of PHAC’s antimicrobial resistance (AMR) activities since 2013-2014. Data collection methods included: Literature review, document and file review, key informant interviews (with 47 internal and external stakeholders) and a review of financial data.

March 2019

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: